With all the despondency over the NIH budget situation, I feel the need to broadcast some good news. Last year I blogged on the plummeting funding levels for SBIR and STTR grant applications. I am happy to report that FY12 numbers are out and they may be a lone bright spot on an otherwise bleak NIH funding landscape. What do you think? Good news or too little, too late? Does it make you want to run out and write a Phase II SBIR?:
SBIR ONLY:
| YEAR | Phase I | Phase II | Fast Track |
| 2008 | 27.1% | 47.7% | 31.4% |
| 2009 | 21.9% | 40.5% | 23.1% |
| 2010 | 13.7% | 33.5% | 15.6% |
| 2011 | 11.5% | 29.8% | 10.3% |
| 2012 | 15.6% | 39.9% | 15.9% |
| YEAR | Total # SBIR/STTR Applications Reviewed | Total # SBIR/STTRApplications Awarded | Total Funding SBIR/STTR |
| 2008 | 4356 | 1242 | $341,059,957 |
| 2009 | 4529 | 1108 | $339,594,601 |
| 2010 | 6338 | 1079 | $334,370,963 |
| 2011 | 6415 | 902 | $311,127,665 |
| 2012 | 5847 | 1095 | $366,812,604 |
